Virtual Medicinal Product (VMP)
-
Atazanavir 150mg capsules
Name Details
Current Name
Atazanavir 150mg capsules
|
Start Date
19-04-2004
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- capsule
- Unit Dose UOM
- capsule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral capsule
- Ontology Form/Route
- capsule.oral
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
J05AE08
BNF |
Current BNF
05030100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
05030100
|
Start Date
24-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
41758611000001101 |
09-05-2023 |
|
413594004 |
08-08-2005 |
08-05-2023 |
7353011000001104 |
19-04-2004 |
07-08-2005 |
VMP Ingredients
Name
Atazanavir sulfate
Basis of strength description
Based on Base Substance
BOSS
Atazanavir
Strength and UOM (Nmr)
150
Strength and UOM (Dmr)
Parent Products
-
VTM
Atazanavir
-
VMP
(Current) Atazanavir 150mg capsules
Virtual Medicinal Product Pack (VMPP) Information